Better Therapeutics Inc
BTTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$247.65M
Close$
$0.04
36400% upside
Current Fair Value
36400% upsideUndervalued by 36400% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $247.65 Million |
|---|---|
| Enterprise Value | $255.36 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 1.69 |
| Outstanding Shares | 38,495,150 |
Return
| Return on Equity | 317.73% |
|---|---|
| Return on Assets | -294.47% |
| Return on Invested Capital | 1440.88% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -8 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -1.44 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$5.04 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$6.58 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Better Therapeutics Inc
1 employees